Nuo Therapeutics director exercises options, gets grant
Rhea-AI Filing Summary
Nuo Therapeutics director and 10% owner Scott M. Pittman reported a compensation-related option exercise and new option grant. He exercised options for 40,000 shares of common stock at $1.00 per share. In a net share settlement, the issuer withheld 39,604 shares at a closing price of $1.01 to cover the exercise cost, and Pittman received 396 net shares.
After the transactions, he directly owns 5,440,000 shares of common stock. He also received a new grant of options for 30,000 shares with an exercise price of $1.01 per share that fully vest as of June 30, 2027 and expire on June 29, 2036. These actions reflect routine equity compensation and tax withholding rather than open-market trading.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 396 shares
Net Buy
4 txns
Insider
Pittman Scott M.
Role
Director, 10% Owner
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to purchase common stock | 40,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 40,000 | $1.00 | $40K |
| Exercise Price or Tax Liability | Common Stock | 39,604 | $1.01 | $40K |
| Grant/Award | Option to purchase common stock | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Option to purchase common stock — 30,000 shares (Direct);
Common Stock — 5,400,396 shares (Direct)
Footnotes (3)
- F1. Represents a net exercise of outstanding stock options. The reporting person received 396 shares of common stock on the net exercise of option to purchase 40,000 shares of common stock. The issuer withheld 39,604 shares of common stock underlying the option for payment of the exercise price using the closing price of $1.01.
- F2. 15,000 options exercisable on 07/01/2016 and 25,000 options exercisable on 01/01/2017.
- F3. The options fully vest as of June 30, 2027.
Key Figures
Options exercised: 40,000 shares
Exercise price: $1.00 per share
Shares withheld: 39,604 shares
+5 more
8 metrics
Options exercised
40,000 shares
Common stock options exercised on June 30, 2026 at $1.00
Exercise price
$1.00 per share
Price for exercised 40,000-share option
Shares withheld
39,604 shares
Withheld to pay exercise cost using $1.01 closing price
Net shares received
396 shares
Net from 40,000-share option after withholding
Shares owned after
5,440,000 shares
Direct common stock holdings after transactions
New option grant
30,000 options
Options to purchase common stock at $1.01
New option vesting
June 30, 2027
Date options for 30,000 shares fully vest
New option expiration
June 29, 2036
Expiration date of 30,000-share option grant
Key Terms
net exercise, stock options, derivative security, grant, award, or other acquisition, +1 more
5 terms
net exercise financial
"Represents a net exercise of outstanding stock options."
A net exercise is a way to convert stock options into shares without paying cash up front: instead of handing over money to buy the optioned shares, the holder receives only the number of shares equal to the option’s value after the company withholds a portion of shares to cover the exercise price and taxes. It matters to investors because it changes how many new shares are issued, affects dilution of existing shareholders, and alters company cash flow compared with a cash exercise.
stock options financial
"Represents a net exercise of outstanding stock options."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
grant, award, or other acquisition financial
"Grant, award, or other acquisition"
Option to purchase common stock financial
"Option to purchase common stock"
FAQ
What insider transactions did Scott M. Pittman report for Nuo Therapeutics (AURX)?
Scott M. Pittman reported exercising stock options for 40,000 Nuo Therapeutics shares and receiving a new 30,000-share option grant. The exercise was settled mostly through share withholding to cover the cost, resulting in 396 additional shares owned directly.
Was Scott M. Pittman’s Nuo Therapeutics transaction an open-market sale?
The Form 4 shows no open-market sale. Instead, 39,604 shares were withheld by the issuer to pay the option exercise cost using a $1.01 closing price, leaving Pittman with 396 net shares from a 40,000-share option exercise.
What are the terms of Scott M. Pittman’s new Nuo Therapeutics stock option grant?
Pittman received options for 30,000 Nuo Therapeutics shares at a $1.01 exercise price. The options fully vest as of June 30, 2027 and expire on June 29, 2036, providing long-dated equity-based compensation tied to future company performance.
AI-generated analysis. How Rhea-AI works. Not financial advice.
